1. TBX2 overexpression promotes proliferation and invasion through epithelial‑mesenchymal transition and ERK signaling pathway
   Xingyu Liu et al, 2018, Experimental and Therapeutic Medicine CrossRef
2. Context-dependent T-BOX transcription factor family: from biology to targeted therapy
   Siwen Li et al, 2024, Cell Communication and Signaling CrossRef
3. Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
   Yan-Xia Wang et al, 2022, Signal Transduction and Targeted Therapy CrossRef
4. TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma
   Reiko Tasaka et al, 2017, Oncology Letters CrossRef
5. T‑box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma
   Yuta Inoue et al, 2021, Oncology Letters CrossRef
6. Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2
   Bo Zhou et al, 2019, Nucleic Acids Research CrossRef
7. Predicting recurrence in intermediate‑ and high‑risk stage IB‑IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post‑radical hysterectomy: The role of TBX2 expression
   Takuya Noda et al, 2024, Oncology Letters CrossRef